Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIO-RAD LABORATORIES, INC. (BIO)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   8-K10-K10-K10-K10-K10-K10-K10-K
Cash flows from operating activities:          
    Cash received from customers          
    Cash paid to suppliers and employees          
    Interest paid, net  -2.3-21.6-22.3-22.7-22.2-21.3-20.8-20.8
    Income tax payments, net  -134.7-65.2-45.1-62.4-52.1-38.4-31.7-28.9
    Investment proceeds and miscellaneous receipts, net   21.531.726.418.415.712.015.7
        Net cash provided by operating activities  1,313.0575.3457.9285.5104.1216.4186.2273.3
   
Cash flows from investing activities:          
    Capital expenditures   -98.9-98.5-129.8-111.3-141.4-112.0-121.0
    Payments for purchases of marketable securities and investments   -248.5-371.5-371.0-282.7-278.1-294.5-205.7
    Proceeds from Sale of Debt Securities, Available-for-sale   89.7104.677.097.576.978.775.7
    Proceeds from maturities of marketable securities and investments   278.3226.9225.3202.2143.0170.8120.4
        Net cash used in investing activities  -784.4-60.3-208.9-187.0-175.6-213.9-166.9-190.5
   
Cash flows from financing activities:          
    Proceeds from Debt, Net of Issuance Costs      0.00.0 -1.6
    Payments on long-term borrowings   -426.9-0.6-3.0-0.3-0.3-0.3-0.3
    Proceeds from Issuance of Common Stock   7.35.05.314.611.38.215.1
        Net cash used in financing activities  -55.4-523.0-22.8-48.70.39.08.611.7
   
Cash and cash equivalents          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy